A Single Source of Truth with integrity.


This is one of medicine’s dirty secrets: Most results, including those that appear in top-flight peer-reviewed journals, can’t be reproduced

Glen Begley, Amgen WSJ

The glut of available research technologies have not led to more precise, accurate, and accountable clinical trials, which both Patients and Industry rely on. Rather, the lack of interoperability worsens an erosion of public trust in science driven by a high failure rate in the ability to replicate studies and massive waste in research funding.

MyIRE, on the other hand, was created to become a public utility for scientific integrity: an interoperable, end-to-end solution for reproducible research. For the first time ever, we can reproduce entire clinical trials with the click of a button.

Why It Matters

The current fragmented system isn't working -- for anyone.

1

Safer for Participants

Every year, millions of lives are lost despite the best efforts of imperfect human researchers. Commercial interests shouldn't make that worse. MyIRE's novel volume based model flips the current commercial incentives for research integrity.

2

Built by Investigators, For Investigators

Every day, researchers are bogged down, mired in the distraction of working against and around the tools at their disposal. MyIRE's paperless capable trials empower you to add "y" and find answers.

3

Increased Intellectual Property Fluidity

Transfers of IP between sites, studies, and phases involving multiple softwares puts your intellectual property and budget at risk. We empower you to take charge of your data.

4

Turning Liabilities Into Assets

Duke University is now potentially liable for $800M due to research fraud. This is almost their entire yearly research budget. We can turn your liabilities into revenue producing digital research objects.